Class 4 Medicines Defect Information (caution in use) Bleo-Kyowa, powder for solution for injection, 15,000 IU

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 drug alert for a specific batch of Bleo-Kyowa, Powder for Solution for Injection (Bleomycin sulfate), 15,000 IU. Thi
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news